- Pancreatic Cancer – Therapeutic
Principal Investigator(s) and Department
- Pancreatic cancer is one of the deadliest forms of Cancer with a survival rate of only 3 to 5 percent.
- Current chemotherapy treatments for pancreatic cancer have limited effect. Gemcitabine is the drug most often used to treat metastatic, unresectable pancreatic cancer.
- A novel compound (AS-10) that is selectively toxic to cancer cells, inducing apoptosis (cell death) and in a mouse model found to inhibit tumor growth in pancreatic cancer.
- Compound is more than 100 times more potent than gemcitabine.